Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Covidien, a leading global provider of healthcare products, announced several financial reporting changes. The Specialty Chemicals business, previously reported in discontinued operations, has been reclassified to continuing operations within the Pharmaceuticals segment as a result of the Company’s decision to cease marketing the business for sale. The reclassification of this business to continuing operations will impact the Company’s results of operations and cash flows from continuing operations.

Today in Financial Reports...keeping you current

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address